Skip to content

Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease

Effect of Low Dietary Salicylate on Biochemical Markers of Aspirin Exacerbated Respiratory Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01778465
Enrollment
7
Registered
2013-01-29
Start date
2013-05-31
Completion date
2014-05-31
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspirin Exacerbated Respiratory Disease, Aspirin Sensitivity, Asthma, Chronic Rhinosinusitis

Keywords

Chronic Rhinosinusitis, Aspirin exacerbated respiratory disease, Asthma, Aspirin sensitivity, Salicylate

Brief summary

Aspirin-Exacerbated Respiratory Disease, or AERD, consists of aspirin sensitivity, asthma and nasal polyps. It is currently managed by chronic steroid use, multiple endoscopic sinus surgeries and/or aspirin desensitization. However, these treatments have potential adverse effects. A theory has been postulated that decreasing the level of dietary salicylates may help in long-term control of disease. A current trial is in the works to evaluate the clinical outcomes of decreased salicylate, but measurements of biochemical markers of disease has not yet been done. The hypothesis is that decreased dietary salicylates will result in a decrease in urinary salicylates and inflammatory markers of disease, cys-leukotrienes, which are typically elevated in this disease.

Interventions

Participants followed a 7 days period under a Low salicylate diet

BEHAVIORALNormal Diet

Participants followed a 7 days period under a Normal Diet

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* adult patients * Aspirin-exacerbated respiratory disease

Exclusion criteria

* recent use of Prednisone or other systemic steroids (greater than 3 doses in past 3 months) * Endoscopic sinus surgery or polypectomy within the past 6 months * Other significant systemic disease, including renal failure, or immunocompromised state.

Design outcomes

Primary

MeasureTime frame
Urinary Levels of Cys-Leukotrienes14 days after commencement
Urinary Salicyluric Acid Levels14 days after commencement
Urinary Salicylic Acid Levels14 days after enrollment
Urinary Creatinine Levels14 days after commencement

Secondary

MeasureTime frameDescription
Sino-Nasal Outcome Test (SNOT-22)14 days after commencementThe Sino-Nasal Outcome Test (SNOT-22) is a validated 22-item Chronic rhinosinusitis-specific instrument which is scored using a scale where 0=No problem, 1=Very mild problem, 2=Mild or slight problem, 3=Moderate problem, 4=Severe problem, and 5=Problem as bad as it can be. Higher scores on the SNOT-22 survey items suggest worse patient functioning or symptom severity (total score range: 0-110)

Countries

Canada

Participant flow

Participants by arm

ArmCount
All Study Participants
Participants followed a low salicylate diet for one week. Then, participants continued with a normal diet for one week.
7
Total7

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous55 years
STANDARD_DEVIATION 13.1
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 70 / 7
other
Total, other adverse events
0 / 70 / 7
serious
Total, serious adverse events
0 / 70 / 7

Outcome results

Primary

Urinary Creatinine Levels

Time frame: 14 days after commencement

ArmMeasureValue (MEDIAN)
Low Salicylate DietUrinary Creatinine Levels9.9 mmol/L
Normal DietUrinary Creatinine Levels15.3 mmol/L
Primary

Urinary Levels of Cys-Leukotrienes

Time frame: 14 days after commencement

ArmMeasureValue (MEDIAN)
Low Salicylate DietUrinary Levels of Cys-Leukotrienes874.05 pg/ml
Normal DietUrinary Levels of Cys-Leukotrienes771.99 pg/ml
Primary

Urinary Salicylic Acid Levels

Time frame: 14 days after enrollment

ArmMeasureValue (MEDIAN)
Low Salicylate DietUrinary Salicylic Acid Levels0.6 ng/ml
Normal DietUrinary Salicylic Acid Levels0.92 ng/ml
Primary

Urinary Salicyluric Acid Levels

Time frame: 14 days after commencement

ArmMeasureValue (MEDIAN)
Low Salicylate DietUrinary Salicyluric Acid Levels44.21 ng/ml
Normal DietUrinary Salicyluric Acid Levels23.82 ng/ml
Secondary

Sino-Nasal Outcome Test (SNOT-22)

The Sino-Nasal Outcome Test (SNOT-22) is a validated 22-item Chronic rhinosinusitis-specific instrument which is scored using a scale where 0=No problem, 1=Very mild problem, 2=Mild or slight problem, 3=Moderate problem, 4=Severe problem, and 5=Problem as bad as it can be. Higher scores on the SNOT-22 survey items suggest worse patient functioning or symptom severity (total score range: 0-110)

Time frame: 14 days after commencement

ArmMeasureValue (MEDIAN)
Low Salicylate DietSino-Nasal Outcome Test (SNOT-22)44 score on a scale
Normal DietSino-Nasal Outcome Test (SNOT-22)66 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026